You are here

Article Text

Article menu
Download PDFPDF
Aetiology/Harm
Systematic review with meta analysis
The risk of arterial thrombosis increases with the use of combined oral contraceptives
  1. Øjvind Lidegaard
  1. Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  1. Correspondence to : Dr Øjvind Lidegaard, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen, DK-2100, Denmark; Oejvind.Lidegaard{at}regionh.dk

https://doi.org/10.1136/ebmed-2015-110303

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Roach RE, Helmerhorst FM, Lijfering WM, et al. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev 2015;8:CD011054.

    Context

    While the risk of venous thrombosis with use of combined oral contraceptives (COC) is now convincingly quantified to be threefold to sixfold increased, depending mainly on the type of progestogen, there are few and less consistent studies on the risk of arterial endpoints. Therefore, a meta-analysis on available evidence might be relevant.

    Method

    This Cochrane review includes data from 24 studies assessing the risk of thrombotic stroke and/or myocardial infarction in women of reproductive age using COC as compared with non-users. Criteria for including and excluding studies were specified, as was information on categorising the studies’ …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.